GILEAD SCIENCES, INC.·4

Jul 2, 4:14 PM ET

O'Day Daniel Patrick 4

Research Summary

AI-generated summary

Updated

Gilead (GILD) CEO Daniel O'Day Sells 15,000 Shares

What Happened Daniel Patrick O'Day, Chairman & CEO of Gilead Sciences (GILD), disposed of 15,000 shares on July 1, 2026 in two reported transactions. He sold 11,900 shares at $126.09 each for $1,500,467 and 3,100 shares at $127.08 each for $393,933, for total proceeds of approximately $1,894,400. These were sales (dispositions), not purchases.

Key Details

  • Transaction dates: July 1, 2026; Form 4 filed July 2, 2026 (timely filing).
  • Reported trades:
    • 11,900 shares @ $126.09 = $1,500,467
    • 3,100 shares @ $127.08 = $393,933
  • Total shares sold: 15,000; total proceeds ≈ $1,894,400.
  • Footnotes:
    • F1: Trades were made pursuant to a Rule 10b5-1 trading plan adopted Feb 25, 2026.
    • F2/F3: Reported sale-price ranges for the two blocks are $125.59–$126.55 and $126.595–$127.44; detailed per-price breakdown is available upon request.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Transaction type code: S = Sale (disposition).

Context Sales executed under a 10b5-1 plan are pre-arranged and typically indicate pre-planned dispositions rather than ad-hoc trading based on nonpublic information. For retail investors, such planned sales are common for executives to diversify or meet personal liquidity needs; they are not a direct, unambiguous signal about the company's near-term prospects.